Articles

Podcasts

Videos

Both treatments showed tolerable safety as in the phase 2 and 3 trials, but when evaluated in four body regions on patients, upadacitinib surpassed dupilumab in all of them.  

Upadacitinib Provides Greater Efficacy Compared with Dupilumab for Atopic Dermatitis

Although sharing a common feature of male predominance, alopecia did not seem to occur more frequently in AS patients. 

Ankylosing Spondylitis Not Linked to Increased Risk of Alopecia 

Investigators from found that 12.12% of patients with a previous skin disease diagnosis developed an adverse skin reaction following a COVID-19 vaccine injection.

Adverse Skin Reactions Rare Following COVID-19 Vaccination

45% of study participants were either dissatisfied or very dissatisfied with their current medical treatment. 

Patients with Hidradenitis Suppurativa Often Report Treatment Dissatisfaction 

The pivotal DERMIS trial author discusses extended assessment and prescribing strategies for the latest psoriasis agent.

Mark Lebwohl, MD: Optimizing Roflumilast Cream in Dermatology

A retrospective analysis suggests there are significant disparities in dermatologist visit duration based on patient race and ethnicity.

Asian Patients with Psoriasis Receive Significantly Less Time with Dermatologists

Dermatologist Raj Chovatiya, MD, PhD, discusses practical use of the newest topical therapy approved by the FDA.

How Roflumilast Cream Fits into Plaque Psoriasis Care Strategy

The therapy targets both IL-12 and IL-23 cytokines offering a new option for children 6 years and older living with active psoriatic arthritis. 

Ustekinumab Becomes First FDA-Approved Biologic for Pediatric Psoriatic Arthritis

The indication to Arcutis makes the once-daily topical cream the first marketed PDE4 inhibitor of its kind.

FDA Approves Roflumilast Cream for Adolescent, Adult Plaque Psoriasis

Results from this AoU database study found that Black and Hispanic patients and individuals with physical disabilities were at an increased risk of tinea versicolor.

Prevalence of Tinea Versicolor Higher in Underrepresented Groups

Vitiligo

Vitiligo condition center page is a comprehensive resource for clinical news and insights on the dermatologic condition. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for the affected skin of vitiligo patients.

Acne

The HCPLive acne page is a resource for medical news and expert insights on dermatological disease. This page features expert-led coverage, articles, videos, and research on the therapies and development of treatments for chronic acne, and more.

Atopic Dermatitis

Atopic Dermatitis condition center page, resources on the topics of medical news and expert insight into eczema can be found. Content includes articles, interviews, videos, podcasts, and breaking news on dermatitis research, treatment, and drug development.

Chronic Idiopathic Urticaria

The HCPLive chronic idiopathic urticaria page is a comprehensive resource for clinical news and insights on CIU. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for urticaria, and more.

Plaque Psoriasis

The HCPLive plaque psoriasis page is a resource for medical news and expert insights on psoriasis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for psoriatic disease, and more.

Rosacea

On the HCPLive rosacea page, resources on the topics of medical news and expert insight into acne rosacea can be found. Content includes articles, interviews, videos, podcasts, and breaking news on the skin condition, and more.

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.